Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Blueprint MedicinesAlkermesUltragenyx PharmaceuticalZai LabPPD
SymbolNASDAQ:BPMCNASDAQ:ALKSNASDAQ:RARENASDAQ:ZLABNASDAQ:SDGR
Price Information
Current Price$66.20$15.43$52.50$59.92$41.30
52 Week RangeBuyHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$105.75$22.42$77.78$52.89$50.00
% Upside from Price Target59.74% upside45.28% upside48.15% upside-11.74% downside21.07% upside
Trade Information
Market Cap$3.62 billion$2.50 billion$3.05 billion$2.98 billion$2.47 billion
Beta1.311.672.110.96N/A
Average Volume975,4312,011,865589,932496,1671,593,376
Sales & Book Value
Annual Revenue$66.51 million$1.17 billion$103.71 million$12.98 millionN/A
Price / Sales53.782.0829.30268.23N/A
CashflowN/A$0.57 per shareN/AN/AN/A
Price / CashN/A27.22N/AN/AN/A
Book Value$9.44 per share$6.89 per share$11.32 per share$5.07 per shareN/A
Price / Book7.012.244.6411.82N/A
Profitability
Net Income$-347,690,000.00$-196,620,000.00$-402,730,000.00$-195,070,000.00N/A
EPS($7.27)$0.07($7.36)($3.03)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-522.75%-16.79%-388.30%N/AN/A
Return on Equity (ROE)-72.52%1.58%-52.36%N/AN/A
Return on Assets (ROA)-49.72%0.97%-40.59%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.19%0.25%0.05%N/AN/A
Current Ratio4.85%2.46%8.24%6.27%N/A
Quick Ratio4.85%2.20%8.13%6.14%N/A
Ownership Information
Institutional Ownership Percentage93.77%95.66%N/A63.51%N/A
Insider Ownership Percentage4.02%4.71%7.80%N/AN/A
Miscellaneous
Employees2172,235N/A309392
Shares Outstanding54.03 million157.79 million57.89 million58.11 million63.27 million
Next Earnings Date5/14/2020 (Estimated)4/23/2020 (Estimated)5/4/2020 (Estimated)N/AN/A
OptionableOptionableOptionableOptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel